Many thanks to everyone who responded to the UK NSC stakeholder survey. We will analyse the results and use them to inform any changes needed to the UK NSC stakeholder engagement strategy and activities.
Well over 1 million babies have now been screened for severe combined immune deficiency (SCID) since the September 2021 launch of an in-service evaluation (ISE) in NHS services.
An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
More than 200 stakeholders attended a fascinating UK National Screening Committee (UK NSC) seminar exploring multi-cancer detection tests (MCDs) and their potential use in a screening context. Attendees included academics, clinicians, researchers, industry representatives, patient organisations, screening providers, policy makers …
Cancer Research UK Strategic Evidence Manager Hope Walters talks about her experience of attending the Health Screening Module at the University of Warwick.
Experts discussed the potential role and challenges of surrogate endpoints in cancer screening in a webinar hosted by Cancer Research UK and Consilium Scientific.
Related content and links
About this blog
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.